Balincan USA, Inc.
BCNN · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | – | $0 | $0 | $0 |
| Short-Term Investments | – | $0 | $0 | $0 |
| Receivables | – | $1 | $0 | $0 |
| Inventory | – | $0 | $0 | $0 |
| Other Curr. Assets | – | $0 | $0 | $0 |
| Total Curr. Assets | – | $1 | $0 | $0 |
| Property Plant & Equip (Net) | – | $0 | $0 | $0 |
| Goodwill | – | $0 | $0 | $0 |
| Intangibles | – | $2 | $2 | $2 |
| Long-Term Investments | – | $0 | $0 | $0 |
| Tax Assets | – | $0 | $0 | $0 |
| Other NC Assets | – | $0 | $0 | $0 |
| Total NC Assets | – | $2 | $2 | $2 |
| Other Assets | – | $0 | $0 | $0 |
| Total Assets | – | $3 | $2 | $2 |
| Liabilities | – | – | – | – |
| Payables | – | $3 | $2 | $2 |
| Short-Term Debt | – | $3 | $2 | $2 |
| Tax Payable | – | $0 | $0 | $0 |
| Deferred Revenue | – | $0 | $0 | $0 |
| Other Curr. Liab. | – | $5 | $4 | $4 |
| Total Curr. Liab. | – | $10 | $7 | $7 |
| LT Debt | – | $0 | $0 | $0 |
| Deferred Rev, NC | – | $0 | $0 | $0 |
| Deferred Tax Liab, NC | – | $0 | $0 | $0 |
| Other NC Liab. | – | $0 | $0 | $0 |
| Total NC Liab. | – | $0 | $0 | $0 |
| Other Liabilities | – | $0 | $0 | $0 |
| Cap. Leases | – | $0 | $0 | $0 |
| Total Liabilities | – | $10 | $8 | $8 |
| Equity | – | – | – | – |
| Pref Stock | – | $0 | $0 | $0 |
| Common Stock | – | $0 | $0 | $0 |
| Retained Earnings | – | -$8 | -$6 | -$6 |
| AOCI | – | $1 | $1 | $1 |
| Other Equity | – | -$0 | -$0 | -$0 |
| Total Equity | – | -$7 | -$5 | -$5 |
| Supplemental Information | – | – | – | – |
| Minority Interest | – | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | – | $3 | $2 | $2 |
| Net Debt | $0 | $3 | $2 | $2 |